Addressing patient misconceptions about generics

Posted 02/12/2016

In the face of increasing drug costs, substitution by generics is often used as a strategy by healthcare systems to rein in expenditure. However, patient mis...

Biosimilar rituximab approved in South Korea Biosimilars/News | Posted 02/12/2016
Biosimilars of abatacept Biosimilars/General | Posted 02/12/2016
Mylan and Biocon submit insulin glargine biosim... Biosimilars/News | Posted 02/12/2016
Biosimilars help reduce the costs of cancer care Biosimilars/Research | Posted 02/12/2016
FDA reports record number of generics approvals Generics/General | Posted 02/12/2016
Mylan to make generic hepatitis drug under MPP... Generics/News | Posted 02/12/2016
13th Legal Affairs Conference Conferences | Posted 02/12/2016
15th Biosimilar Medicines Conference Conferences | Posted 02/12/2016
Safety differences in clinical trials for biosi... Biosimilars/Research | Posted 25/11/2016
FDA accepts application for bevacizumab biosimilar Biosimilars/News | Posted 25/11/2016
Assessing analytical comparability for G-CSF bi... Biosimilars/Research | Posted 25/11/2016
FDA amends citizen petition rules to reduce del... Policies & Legislation | Posted 25/11/2016
Policies to address price rises in old generics Generics/Research | Posted 25/11/2016
Portuguese dermatologists’ position on the use... Biosimilars/General | Posted 25/11/2016
First prequalification submissions for generic... Generics/General | Posted 25/11/2016
2nd Biosimilars Summit: Analytical Similarity,... Conferences | Posted 25/11/2016
Extrapolation of indications for biosimilar inf... Biosimilars/Research | Posted 18/11/2016
EMA approves biosimilars of insulin glargine an... Biosimilars/News | Posted 18/11/2016
Therapeutic substitution could save Americans U... Generics/Research | Posted 18/11/2016
Celltrion submits trastuzumab biosimilar applic... Biosimilars/News | Posted 18/11/2016
Dr Reddy’s makes deal with Gland Pharma for US... Generics/News | Posted 18/11/2016
Trials for biosimilar etanercept Biosimilars/Research | Posted 11/11/2016
Differences in efficacy assessment in clinical... Biosimilars/Research | Posted 11/11/2016
FDA accepts application for pegfilgrastim biosi... Biosimilars/News | Posted 11/11/2016
Biosimilars of natalizumab Biosimilars/General | Posted 11/11/2016
Transparency in the Australian pharmaceutical i... Generics/Research | Posted 11/11/2016
TTIP could further delay access to generics Policies & Legislation | Posted 11/11/2016
Trials for biosimilar infliximab Biosimilars/Research | Posted 04/11/2016
Factors affecting generics entry Generics/Research | Posted 04/11/2016
Baxalta and Momenta part ways on adalimumab bio... Biosimilars/News | Posted 04/11/2016
Sandoz petitions FDA over requirements for gene... Generics/General | Posted 04/11/2016
Biosimilars in nephrology in the US Biosimilars/Research | Posted 04/11/2016
WHO proposes provisional implementation of biol... Biosimilars/General | Posted 28/10/2016
Standardizing clinical trials for biosimilars Biosimilars/Research | Posted 28/10/2016
Study design for biosimilar trials Biosimilars/Research | Posted 28/10/2016
Colombia to enforce declaration of public inter... Policies & Legislation | Posted 28/10/2016
Biogen’s infliximab biosimilar gets UK launch Biosimilars/News | Posted 28/10/2016
NOR-SWITCH study finds biosimilar infliximab no... Biosimilars/Research | Posted 21/10/2016


In vitro analysis of follow-on versions of sevelamer Posted 18/11/2016

Authors from the US Food and Drug Administration (FDA) have published details...


Determining the bioequivalence of follow-on iro... Non‐Biological Complex Drugs/Reports | Posted 04/11/2016
FDA to set up abbreviated pathway for complex p... Non‐Biological Complex Drugs/Polices & Legislation | Posted 21/10/2016
Challenges in the assessment of ophthalmic emul... Non‐Biological Complex Drugs/Reports | Posted 07/10/2016
Cancer lab to evaluate bioequivalence of nanosi... Non‐Biological Complex Drugs/News | Posted 23/09/2016
A conference on ‘Equivalence of Complex Drug Pr... Non‐Biological Complex Drugs/News | Posted 09/09/2016
Collaboration to introduce nanotechnologies in... Non‐Biological Complex Drugs/News | Posted 26/08/2016
Iron carbohydrate follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 12/08/2016
Rigorous approach used to approve a follow-on v... Non‐Biological Complex Drugs/Research | Posted 29/07/2016
US guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 10/06/2016
Non-biological complex drugs and their follow-o... Non‐Biological Complex Drugs/Research | Posted 03/06/2016
Is a new pathway for NBCDs on the way in the US? Non‐Biological Complex Drugs/Polices & Legislation | Posted 27/05/2016
Follow-on glatiramer acetate gains European app... Non‐Biological Complex Drugs/News | Posted 13/05/2016
FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015

Generics News Research General


Biosimilars News Research General